Stockreport

TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering

TFF Pharmaceuticals, Inc.  (TFFP) 
PDF FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutica [Read more]